TheraRadar
Data updated: May 26, 2026

HYDROCODONE POLISTIREX AND CHLORPHENIRAMNE POLISTIREX (chlorpheniramine polistirex)

Respiratory Approved 2012-06-29
1
Indication
--
Phase 3 Trials
13
Years on Market

Details

Status
Discontinued
First Approved
2012-06-29
Routes
ORAL
Dosage Forms
SUSPENSION, EXTENDED RELEASE

HYDROCODONE POLISTIREX AND CHLORPHENIRAMNE POLISTIREX Approval History

2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Original
New Indication
New Form
Label Update
2 FDA actions from 2012 to 2015
Nov 2015 SUPPL
Mfg · Manufacturing (CMC)
Jun 2012 ORIGINAL
Update

What HYDROCODONE POLISTIREX AND CHLORPHENIRAMNE POLISTIREX Treats

1 FDA approvals

Originally approved for its first indication in 2012 .

  • Other (1)
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

|
Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

HYDROCODONE POLISTIREX AND CHLORPHENIRAMNE POLISTIREX FDA Label Details

Track HYDROCODONE POLISTIREX AND CHLORPHENIRAMNE POLISTIREX with TheraRadar Pro

Watchlist alerts, full database access, CSV exports across 14,000+ drugs.

Upgrade to Pro

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.